Cargando…
TG1050, an immunotherapeutic to treat chronic hepatitis B, induces robust T cells and exerts an antiviral effect in HBV-persistent mice
OBJECTIVE: To assess a new adenovirus-based immunotherapy as a novel treatment approach to chronic hepatitis B (CHB). METHODS: TG1050 is a non-replicative adenovirus serotype 5 encoding a unique large fusion protein composed of a truncated HBV Core, a modified HBV Polymerase and two HBV Envelope dom...
Autores principales: | Martin, Perrine, Dubois, Clarisse, Jacquier, Emilie, Dion, Sarah, Mancini-Bourgine, Maryline, Godon, Ophélie, Kratzer, Roland, Lelu-Santolaria, Karine, Evlachev, Alexei, Meritet, Jean-François, Schlesinger, Yasmin, Villeval, Dominique, Strub, Jean-Marc, Van Dorsselaer, Alain, Marchand, Jean-Baptiste, Geist, Michel, Brandely, Renée, Findeli, Annie, Boukhebza, Houda, Menguy, Thierry, Silvestre, Nathalie, Michel, Marie-Louise, Inchauspé, Geneviève |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4680198/ https://www.ncbi.nlm.nih.gov/pubmed/25429051 http://dx.doi.org/10.1136/gutjnl-2014-308041 |
Ejemplares similares
-
A meta-analysis of the antiviral activity of the HBV-specific immunotherapeutic TG1050 confirms its value over a wide range of HBsAg levels in a persistent HBV pre-clinical model
por: Kratzer, Roland, et al.
Publicado: (2018) -
Safety and immunogenicity of the therapeutic vaccine TG1050 in chronic hepatitis B patients: a phase 1b placebo-controlled trial
por: Zoulim, Fabien, et al.
Publicado: (2019) -
Intravenous injection of a novel viral immunotherapy encoding human interleukin-7 in nonhuman primates is safe and increases absolute lymphocyte count
por: Coupet, Charles-Antoine, et al.
Publicado: (2022) -
A dataset of 1050-tampered color and grayscale images (CG-1050)
por: Castro, Maikol, et al.
Publicado: (2019) -
Vectorization in an oncolytic vaccinia virus of an antibody, a Fab and a scFv against programmed cell death -1 (PD-1) allows their intratumoral delivery and an improved tumor-growth inhibition
por: Kleinpeter, Patricia, et al.
Publicado: (2016)